Dr. Deepna Jaiswal, D.O

Hematology & Oncology Plano, TX Female
NPI: 1447541594
Total Payments
$50,892
2024 Payments
$710.15
Companies
54
Transactions
399
Medicare Patients
1,921
Medicare Billing
$379,697

Payment Breakdown by Category

Consulting$44,208 (86.9%)
Food & Beverage$6,084 (12.0%)
Education$348.09 (0.7%)
Travel$252.42 (0.5%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $44,208 7 86.9%
Food and Beverage $6,084 371 12.0%
Education $348.09 20 0.7%
Travel and Lodging $252.42 1 0.5%

Top Paying Companies

Company Total Records Latest Year
Daiichi Sankyo Inc. $42,169 109 $0 (2024)
AstraZeneca Pharmaceuticals LP $3,737 18 $0 (2024)
Novartis Pharmaceuticals Corporation $416.42 29 $0 (2024)
Lilly USA, LLC $414.99 29 $0 (2020)
PFIZER INC. $344.08 28 $0 (2024)
Genentech USA, Inc. $331.81 26 $0 (2020)
Amgen Inc. $322.58 18 $0 (2023)
Takeda Pharmaceuticals U.S.A., Inc. $305.00 9 $0 (2020)
PUMA BIOTECHNOLOGY, INC. $297.97 5 $0 (2021)
Clovis Oncology, Inc. $258.19 12 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $710.15 38 Daiichi Sankyo Inc. ($221.50)
2023 $609.83 52 Daiichi Sankyo Inc. ($369.91)
2022 $358.63 39 Daiichi Sankyo Inc. ($233.60)
2021 $1,212 5 Daiichi Sankyo Inc. ($1,028)
2020 $43,981 28 Daiichi Sankyo Inc. ($40,161)
2019 $1,219 92 Genentech USA, Inc. ($160.67)
2018 $2,235 115 Clovis Oncology, Inc. ($237.20)
2017 $566.08 30 Millennium Pharmaceuticals, Inc. ($91.10)

All Payment Transactions

399 individual payment records from CMS Open Payments — Page 16 of 16

Date Company Product Nature Form Amount Type
12/04/2017 TESARO, Inc. ZEJULA (Drug) Food and Beverage In-kind items and services $20.73 General
Category: ONCOLOGY
11/30/2017 Amgen Inc. Kyprolis (Biological) Food and Beverage In-kind items and services $22.97 General
Category: Oncology
11/29/2017 Millennium Pharmaceuticals, Inc. NINLARO (Drug) Food and Beverage In-kind items and services $19.86 General
Category: Oncology
11/29/2017 E.R. Squibb & Sons, L.L.C. EMPLICITI (Biological) Food and Beverage Cash or cash equivalent $12.84 General
Category: Oncology
11/28/2017 Millennium Pharmaceuticals, Inc. VELCADE (Drug) Education In-kind items and services $71.24 General
Category: Oncology
11/16/2017 Amgen Inc. Nplate (Biological), Prolia, XGEVA Food and Beverage In-kind items and services $26.93 General
Category: Hematology
11/15/2017 PFIZER INC. IBRANCE (Drug) Food and Beverage In-kind items and services $11.21 General
Category: ONCOLOGY
11/07/2017 Novartis Pharmaceuticals Corporation AFINITOR (Drug), KISQALI, VOTRIENT Food and Beverage In-kind items and services $15.30 General
Category: ONCOLOGY
11/02/2017 Exelixis Inc. Cabometyx (Drug) Food and Beverage In-kind items and services $44.33 General
Category: Oncology
10/18/2017 Daiichi Sankyo Inc. INJECTAFER (Drug) Food and Beverage In-kind items and services $12.33 General
Category: Anemia
10/17/2017 Seattle Genetics, Inc. ADCETRIS (Biological) Food and Beverage In-kind items and services $17.28 General
Category: Not Applicable
10/16/2017 Amgen Inc. Neulasta (Biological), Vectibix Food and Beverage In-kind items and services $18.95 General
Category: Oncology
10/12/2017 TESARO, Inc. ZEJULA (Drug) Food and Beverage In-kind items and services $15.49 General
Category: ONCOLOGY
10/09/2017 Daiichi Sankyo Inc. INJECTAFER (Drug) Food and Beverage In-kind items and services $18.83 General
Category: Anemia
09/30/2017 AstraZeneca Pharmaceuticals LP LYNPARZA (Drug) Food and Beverage In-kind items and services $15.90 General
Category: Oncology
09/26/2017 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Food and Beverage Cash or cash equivalent $13.55 General
Category: Oncology
08/30/2017 Novartis Pharmaceuticals Corporation AFINITOR (Drug), KISQALI Food and Beverage In-kind items and services $13.50 General
Category: ONCOLOGY
08/29/2017 Merck Sharp & Dohme Corporation KEYTRUDA (Biological) Food and Beverage In-kind items and services $15.89 General
Category: ONCOLOGY
08/15/2017 INSYS Therapeutics Inc SUBSYS (Drug) Food and Beverage In-kind items and services $19.74 General
Category: Breakthrough Cancer Pain
08/09/2017 PFIZER INC. SUTENT (Drug), XALKORI, INLYTA Food and Beverage In-kind items and services $16.15 General
Category: ONCOLOGY;RESPIRATORY
05/18/2017 Lilly USA, LLC CYRAMZA (Drug) Food and Beverage In-kind items and services $13.67 General
Category: Oncology
03/23/2017 Lilly USA, LLC — Food and Beverage In-kind items and services $11.96 General
02/09/2017 Lilly USA, LLC CYRAMZA (Drug) Food and Beverage In-kind items and services $14.19 General
Category: Oncology
01/26/2017 Lilly USA, LLC ALIMTA (Drug), CYRAMZA Food and Beverage In-kind items and services $13.38 General
Category: Oncology
«1…141516

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 21 478 3,017 $229,184 $59,940
2022 20 546 1,836 $312,061 $98,258
2021 17 519 2,358 $283,082 $116,697
2020 15 378 16,334 $269,933 $104,801
Total Patients
1,921
Total Services
23,545
Medicare Billing
$379,697
Procedure Codes
73

All Medicare Procedures & Services

73 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 39 101 $35,350 $12,462 35.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 74 136 $37,550 $12,021 32.0%
96413 Administration of chemotherapy into vein, 1 hour or less Office 2023 22 94 $38,728 $9,182 23.7%
K1034 Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count Office 2023 26 330 $9,900 $3,881 39.2%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 17 39 $9,750 $3,562 36.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 37 55 $9,625 $3,365 35.0%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 15 15 $7,500 $2,353 31.4%
99426 Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month Office 2023 17 48 $7,680 $2,240 29.2%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 13 13 $6,500 $1,729 26.6%
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less Office 2023 11 71 $7,100 $1,536 21.6%
80053 Blood test, comprehensive group of blood chemicals Office 2023 42 142 $7,100 $1,459 20.6%
96415 Administration of chemotherapy into vein, each additional hour Office 2023 11 59 $5,487 $1,271 23.2%
96375 Injection of additional new drug or substance into vein Office 2023 15 97 $6,790 $1,144 16.8%
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count Office 2023 38 147 $4,704 $1,111 23.6%
99427 Principal care management services for a single high-risk disease, each additional 30 minutes of clinical staff time directed by health care professional, per calendar month Office 2023 14 25 $3,000 $900.21 30.0%
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less Office 2023 12 16 $3,040 $647.80 21.3%
96372 Injection of drug or substance under skin or into muscle Office 2023 15 37 $2,220 $361.43 16.3%
J2469 Injection, palonosetron hcl, 25 mcg Office 2023 11 400 $20,800 $337.21 1.6%
36415 Insertion of needle into vein for collection of blood sample Office 2023 22 27 $270.00 $226.80 84.0%
J1100 Injection, dexamethasone sodium phosphate, 1 mg Office 2023 13 1,112 $5,560 $105.52 1.9%
J1200 Injection, diphenhydramine hcl, up to 50 mg Office 2023 14 53 $530.00 $45.04 8.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 111 239 $65,725 $22,721 34.6%
G9678 Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a Office 2022 37 120 $19,200 $19,162 99.8%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 57 110 $38,500 $15,277 39.7%
96413 Administration of chemotherapy into vein, 1 hour or less Office 2022 26 131 $53,972 $14,176 26.3%
123»

About Dr. Deepna Jaiswal, D.O

Dr. Deepna Jaiswal, D.O is a Hematology & Oncology healthcare provider based in Plano, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/25/2011. The National Provider Identifier (NPI) number assigned to this provider is 1447541594.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Deepna Jaiswal, D.O has received a total of $50,892 in payments from pharmaceutical and medical device companies, with $710.15 received in 2024. These payments were reported across 399 transactions from 54 companies. The most common payment nature is "Consulting Fee" ($44,208).

As a Medicare-enrolled provider, Jaiswal has provided services to 1,921 Medicare beneficiaries, totaling 23,545 services with total Medicare billing of $379,697. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.

Practice Information

  • Specialty Hematology & Oncology
  • Location Plano, TX
  • Active Since 04/25/2011
  • Last Updated 02/06/2025
  • Taxonomy Code 207RH0003X
  • Entity Type Individual
  • NPI Number 1447541594

Products in Payments

  • Enhertu (Drug) $41,392
  • INJECTAFER (Drug) $619.95
  • Rubraca (Drug) $258.19
  • ZEJULA (Drug) $194.92
  • XTANDI (Drug) $184.89
  • VERZENIO (Drug) $182.18
  • NINLARO (Drug) $172.84
  • Nerlynx (Drug) $162.04
  • VELCADE (Drug) $156.44
  • NERLYNX (Drug) $135.93
  • AFINITOR (Drug) $135.54
  • LYNPARZA (Drug) $134.91
  • ENHERTU (Drug) $127.82
  • OPDIVO (Biological) $117.97
  • Nplate (Biological) $117.46
  • BOSULIF (Drug) $109.68
  • KEYTRUDA (Biological) $107.66
  • JEVTANA (Drug) $107.38
  • Neulasta (Biological) $101.49
  • IBRANCE (Drug) $90.58

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Hematology & Oncology Doctors in Plano

Ruben Saez, Md, MD

Hematology & Oncology — Payments: $117,913

Hematology & Oncology $117,913

Dr. Thuy Le, M.d, M.D

Hematology & Oncology — Payments: $22,323

Hematology & Oncology $22,323

Andrew Kovoor, Md, MD

Hematology & Oncology — Payments: $13,233

Hematology & Oncology $13,233

Virginia Kinsella, Md, MD

Hematology & Oncology — Payments: $13,129

Hematology & Oncology $13,129

Dr. Wendy Mahone-Johnson, Md, MD

Hematology & Oncology — Payments: $8,818

Hematology & Oncology $8,818

Dr. Nandita Rao, Md, MD

Hematology & Oncology — Payments: $4,337

Hematology & Oncology $4,337